Hypertension Diagnostics, Inc.
HDII
$0.00
$0.000.00%
| 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 | |
|---|---|---|---|---|---|
| Revenue | 800.00 | 13.40K | 34.60K | 118.40K | 1.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 800.00 | 13.40K | 34.60K | 118.40K | 1.84M |
| Cost of Revenue | 184.50K | 258.30K | 146.10K | 410.10K | 1.62M |
| Gross Profit | -183.70K | -244.90K | -111.50K | -291.70K | 216.10K |
| SG&A Expenses | 188.20K | 115.80K | 201.00K | 165.00K | 566.90K |
| Depreciation & Amortization | -- | -- | -- | 4.30K | -- |
| Other Operating Expenses | -- | -- | -- | 53.60K | -- |
| Total Operating Expenses | 372.80K | 374.10K | 347.10K | 633.00K | 2.19M |
| Operating Income | -371.90K | -360.70K | -312.50K | -514.50K | -350.80K |
| Income Before Tax | -478.90K | -442.20K | -448.00K | -568.30K | -403.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -478.90K | -442.20K | -448.00K | -568.30K | -403.50K |
| Earnings from Discontinued Operations | -149.70K | 399.70K | -281.90K | 525.10K | 409.10K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -628.60K | -42.50K | -729.80K | -43.20K | 5.60K |
| EBIT | -371.90K | -360.70K | -312.50K | -514.50K | -350.80K |
| EBITDA | -327.30K | -323.90K | -277.30K | -474.90K | -313.20K |
| EPS Basic | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | 0.00 | -0.02 | 0.00 | 0.00 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 52.39M | 52.39M | 52.39M | 52.35M | 48.31M |
| Average Diluted Shares Outstanding | 52.39M | 59.73M | 52.39M | 52.35M | 55.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
